We are live on
!
Find out more
TRIM
Thompson Rubinstein Investment Management Portfolio holdings
AUM
$311M
1-Year Est. Return
11.71%
This Fund
S&P 500
This Quarter
Est. Return
+3.85%
1 Year Est. Return
+11.71%
3 Year Est. Return
+42.77%
5 Year Est. Return
+48.6%
10 Year Est. Return
–
AUM
$275M
AUM Growth
+$5.69M
(+2.1%)
Cap. Flow
-$2.81M
Cap. Flow
% of AUM
-1.02%
Top 10 Holdings %
Top 10 Hldgs %
39.92%
Holding
79
New
2
Increased
5
Reduced
50
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BIVV
Bioverativ Inc. Common Stock
BIVV
|
+$831K |
| 2 |
QEP
QEP RESOURCES, INC.
QEP
|
+$600K |
| 3 |
Varex Imaging
VREX
|
+$461K |
| 4 |
CVS Health
CVS
|
+$252K |
| 5 |
AbbVie
ABBV
|
+$61.1K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$517K |
| 2 |
Biogen
BIIB
|
+$297K |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$281K |
| 4 |
Hubbell
HUBB
|
+$272K |
| 5 |
Johnson & Johnson
JNJ
|
+$219K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.31% |
| 2 | Industrials | 23.16% |
| 3 | Technology | 16.41% |
| 4 | Energy | 10.11% |
| 5 | Consumer Staples | 8.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
PACCAR
PCAR
$69.7B
| $19M | 6.9% |
424,457
| – | – |
|
|
WBA
2
DELISTED
Walgreens Boots Alliance
WBA
| $13.4M | 4.87% |
161,371
-3,345
| -2% | -$281K |
|
3
Apple
AAPL
$4.98T
| $11.2M | 4.06% |
311,580
-5,496
| -2% | -$181K |
|
4
Home Depot
HD
$338B
| $10.7M | 3.87% |
72,628
-100
| -0.1% | -$14.2K |
|
|
5
Hubbell
HUBB
$25.4B
| $9.63M | 3.5% |
80,196
-2,267
| -3% | -$272K |
|
6
Intel
INTC
$452B
| $9.44M | 3.43% |
261,655
-5,230
| -2% | -$189K |
|
7
Costco
COST
$422B
| $9.23M | 3.35% |
55,060
-575
| -1% | -$96.4K |
|
|
8
Biogen
BIIB
$30.1B
| $9.23M | 3.35% |
33,747
-1,051
| -3% | -$297K |
|
9
Woodward
WWD
$24.6B
| $9.09M | 3.3% |
133,788
-1,680
| -1% | -$116K |
|
|
10
Johnson & Johnson
JNJ
$645B
| $9.09M | 3.3% |
72,954
-1,830
| -2% | -$219K |
|
11
IBM
IBM
$205B
| $6.88M | 2.5% |
41,335
-1,252
| -3% | -$210K |
|
12
Waters Corp
WAT
$36.8B
| $6.58M | 2.39% |
42,102
| – | – |
|
13
PepsiCo
PEP
$191B
| $6.28M | 2.28% |
56,115
| – | – |
|
14
Microsoft
MSFT
$2.92T
| $6M | 2.18% |
91,041
-1,773
| -2% | -$114K |
|
15
SLB Ltd
SLB
$77.7B
| $5.82M | 2.11% |
74,535
-2,092
| -3% | -$171K |
|
16
Deere & Co
DE
$167B
| $5.72M | 2.08% |
52,526
-991
| -2% | -$107K |
|
|
17
AbbVie
ABBV
$462B
| $5.66M | 2.06% |
86,904
+972
| +1% | +$61.1K |
|
18
ExxonMobil
XOM
$639B
| $5.39M | 1.96% |
65,769
-1,550
| -2% | -$129K |
|
|
FLIR
19
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $4.76M | 1.73% |
131,115
-1,853
| -1% | -$66.8K |
|
|
AEGN
20
DELISTED
Aegion Corp
AEGN
| $4.61M | 1.67% |
201,091
-2,882
| -1% | -$66.3K |
|
21
Colgate-Palmolive
CL
$73.7B
| $4.53M | 1.65% |
61,939
+308
| +0.5% | +$21.6K |
|
22
Medtronic
MDT
$109B
| $4.53M | 1.64% |
56,178
-1,918
| -3% | -$150K |
|
23
EQT Corp
EQT
$32.7B
| $4.51M | 1.64% |
135,672
| – | – |
|
24
Flowserve
FLS
$9.18B
| $4.4M | 1.6% |
90,899
-2,302
| -2% | -$112K |
|
25
Novartis
NVS
$300B
| $4.36M | 1.58% |
65,444
-536
| -0.8% | -$35.7K |
|
Similar funds
CFS
SVWA
SAS
LYV
TAT
NAP
OAMU
TCM
Thompson Rubinstein Investment Management's Q1 2017 Portfolio in Review
As of Q1 2017, Thompson Rubinstein Investment Management held 79 positions worth $275M, up 2.1% from $270M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Trading was light in Q1 2017: portfolio turnover was 2.5%. Thompson Rubinstein Investment Management opened 2 new positions and made no exits, leaving the 79-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 26% a quarter earlier, followed by Industrials and Technology.
- Thompson Rubinstein Investment Management's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 16,864 shares worth $918K.
- Thompson Rubinstein Investment Management added most to QEP RESOURCES, INC. in Q1 2017, an estimated $600K increase.
- Thompson Rubinstein Investment Management's biggest Q1 2017 reduction was Varian Medical Systems, Inc., cutting an estimated $517K.
- Thompson Rubinstein Investment Management's ten largest holdings make up 40% of its $275M portfolio in Q1 2017.
- Thompson Rubinstein Investment Management opened 2 new positions and closed 0 in Q1 2017.
- Thompson Rubinstein Investment Management's portfolio value rose 2.1% quarter-over-quarter to $275M.
Based on Thompson Rubinstein Investment Management's 13F filing for Q1 2017, filed 6 Apr 2017.